# BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

Page: https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-marc-salzberg-m-d-airway-therapeutics
Text version: https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-marc-salzberg-m-d-airway-therapeutics.md
Podcast: [Business Of Biotech](https://stenobird.com/podcast/business-of-biotech-123501)
Published: 2026-01-19T11:00:00+00:00
Episode link: https://www.buzzsprout.com/1011661/episodes/18511357-bob-jpm-marc-salzberg-m-d-airway-therapeutics.mp3
Audio file: https://www.buzzsprout.com/1011661/episodes/18511357-bob-jpm-marc-salzberg-m-d-airway-therapeutics.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bob-jpm-marc-salzberg-m-d-airway-therapeutics
Duration seconds: 2168

## Resource

We love to hear from our listeners. Send us a message. The Business of Biotech was back in San Francisco for the J.P. Morgan Healthcare Conference (January 12 - 15) and this week we sit down with Marc Salzberg, M.D., CEO, CMO, and Board Chair at Airway Therapeutics, a company developing a recombinant version of human surfactant protein D for several respiratory, inflammatory, and infectious diseases including bronchopulmonary dysplasia (BPD), which is currently in Phase 2b/3 trials. Brian ta...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bob-jpm-marc-salzberg-m-d-airway-therapeutics/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-marc-salzberg-m-d-airway-therapeutics.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.